IRTC250117C35000
- 42.60
- 0.000.00%
iRhythm Technologies Newsroom
IRhythm Technologies Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $120
Express News | IRhythm Technologies Inc : Oppenheimer Raises Target Price to $120 From $105
The Zacks Analyst Blog Highlights Tempus AI, IRhythm Technologies and SOPHiA GENETICS
Oppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)
Wearable Patch Market Report 2025, With Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, IRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry
Is It Time To Consider Buying IRhythm Technologies, Inc. (NASDAQ:IRTC)?
IRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $111
Insiders At IRhythm Technologies Sold US$8.0m In Stock, Alluding To Potential Weakness
Goldman Sachs Maintains IRhythm Technologies(IRTC.US) With Hold Rating, Raises Target Price to $91
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $95
Strategic Growth and Expansion of Irhythm Technologies: A Promising Future in Arrhythmia Detection
J.P. Morgan Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $97
IRhythm Technologies Is Maintained at Buy by Canaccord Genuity
CCORF Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $152
Express News | IRhythm Technologies Inc : Canaccord Genuity Raises Target Price to $152 From $125
Insider Sale: CBO and CLO of $IRTC (IRTC) Sells 2,492 Shares
IRhythm Technologies Price Target Announced at $86.00/Share by Wells Fargo
IRhythm Technologies Analyst Ratings